NCT06409494View on ClinicalTrials.gov

Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

May 31, 2026

Conditions
Varicella Zoster Virus InfectionHerpes Zoster
Interventions
BIOLOGICAL

EuHZV

Drug(injection)

BIOLOGICAL

Shingrix

Drug(injection)

Trial Locations (1)

Unknown

The Catholic University of Eunpyeong St.Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

EuBiologics Co.,Ltd

INDUSTRY

NCT06409494 - Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years | Biotech Hunter | Biotech Hunter